The University of Chicago Header Logo

Connection

Sudha Yarlagadda to Neoplasm Recurrence, Local

Back to Details
This is a "connection" page, showing publications Sudha Yarlagadda has written about Neoplasm Recurrence, Local.
Sudha Yarlagadda
Connection Strength
0.070
Neoplasm Recurrence, Local
  1. Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial. JAMA Netw Open. 2025 Dec 01; 8(12):e2549109.
    View in: PubMed
    Score: 0.036
  2. Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8829-8842.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.